ORIGINAL ARTICLE
Year : 2022 | Volume
: 67 | Issue : 6 | Page : 639--644
Risk of atrial fibrillation in pemphigus vulgaris
Nastaran Namazi1, Shahram Ariaeenejad1, Mitra Esmailii Azad2, Mehdi Pishgahi3
1 From the Department of Dermatology, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2 Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
3 Department of Cardiology, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Correspondence Address:
Nastaran Namazi
Department of Dermatology, Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran
Iran
Background: Pemphigus vulgaris (PV) is a rare immunobullous disease with a higher mortality rate than the general population. The aim of this study was to investigate P-wave duration and P-wave dispersion (PWD) in patients with PV as predictors of atrial fibrillation (AF). Materials and Methods: In this case-control study, the risk of AF development was determined by measuring maximum and minimum P-wave duration (P-max and P-min) and PWD in 45 PV patients and 45 healthy individuals. The incidence of metabolic syndrome was evaluated. Results: PWD and P-max values of the study group were significantly higher than those of the control group. No difference was observed between PWD with regards to disease duration and disease phenotype (p > 0.05). There was no significant difference regarding the prevalence of metabolic syndrome in PV patients compared with the control group. Conclusion: PWD and P-max, which are accepted as risk factors for AF development, were found to be higher in PV patients. Some components of metabolic syndrome were more prevalent in PV patients. It seems that there is an increased risk of CVD and AF in PV patients.
How to cite this article:
Namazi N, Ariaeenejad S, Azad ME, Pishgahi M. Risk of atrial fibrillation in pemphigus vulgaris.Indian J Dermatol 2022;67:639-644
|
How to cite this URL:
Namazi N, Ariaeenejad S, Azad ME, Pishgahi M. Risk of atrial fibrillation in pemphigus vulgaris. Indian J Dermatol [serial online] 2022 [cited 2023 Jun 2 ];67:639-644
Available from: https://www.e-ijd.org/article.asp?issn=0019-5154;year=2022;volume=67;issue=6;spage=639;epage=644;aulast=Namazi;type=0 |
|
|
|
